Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated Post date May 16, 2022 — 08:44 Post Lock Read More Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More 45 stocks received institutional buy ratings today, 12 stocks rose more than 20%_Oriental Fortune Network Post date April 29, 2022 — 19:37 Post Lock Read More The balance of the two financing and financing has shrunk by 8.798 billion yuan, and the leveraged funds have increased significantly by 64 shares. Post date April 28, 2022 — 15:43 Post Lock Read More Changsheng Emerging Growth Mixed Net Worth Down 4.53% Post date April 26, 2022 — 07:02 Post Lock Read More Changsheng Internet + mixed net worth fell 4.64%_Sina Finance_Sina.com Post date April 26, 2022 — 06:56 Post Lock Read More 4.525 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 25, 2022 — 18:15 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational sadness in medicine, long-lasting can be more joyful, postal courier tracking number, postal courier inquiry, postal courier parcel inquiry, postal courier parcel inquiry Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term. Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term Post date April 24, 2022 — 15:31 Post Lock Read More 2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year. Post date April 18, 2022 — 13:42 Post Lock Read More Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More 45 stocks received institutional buy ratings today, 12 stocks rose more than 20%_Oriental Fortune Network Post date April 29, 2022 — 19:37 Post Lock Read More The balance of the two financing and financing has shrunk by 8.798 billion yuan, and the leveraged funds have increased significantly by 64 shares. Post date April 28, 2022 — 15:43 Post Lock Read More Changsheng Emerging Growth Mixed Net Worth Down 4.53% Post date April 26, 2022 — 07:02 Post Lock Read More Changsheng Internet + mixed net worth fell 4.64%_Sina Finance_Sina.com Post date April 26, 2022 — 06:56 Post Lock Read More 4.525 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 25, 2022 — 18:15 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational sadness in medicine, long-lasting can be more joyful, postal courier tracking number, postal courier inquiry, postal courier parcel inquiry, postal courier parcel inquiry Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term. Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term Post date April 24, 2022 — 15:31 Post Lock Read More 2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year. Post date April 18, 2022 — 13:42 Post Lock Read More Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery Post date May 6, 2022 — 22:37 Post Lock Read More The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More 45 stocks received institutional buy ratings today, 12 stocks rose more than 20%_Oriental Fortune Network Post date April 29, 2022 — 19:37 Post Lock Read More The balance of the two financing and financing has shrunk by 8.798 billion yuan, and the leveraged funds have increased significantly by 64 shares. Post date April 28, 2022 — 15:43 Post Lock Read More Changsheng Emerging Growth Mixed Net Worth Down 4.53% Post date April 26, 2022 — 07:02 Post Lock Read More Changsheng Internet + mixed net worth fell 4.64%_Sina Finance_Sina.com Post date April 26, 2022 — 06:56 Post Lock Read More 4.525 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 25, 2022 — 18:15 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational sadness in medicine, long-lasting can be more joyful, postal courier tracking number, postal courier inquiry, postal courier parcel inquiry, postal courier parcel inquiry Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term. Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term Post date April 24, 2022 — 15:31 Post Lock Read More 2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year. Post date April 18, 2022 — 13:42 Post Lock Read More Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry Post date May 6, 2022 — 18:35 Post Lock Read More What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More 45 stocks received institutional buy ratings today, 12 stocks rose more than 20%_Oriental Fortune Network Post date April 29, 2022 — 19:37 Post Lock Read More The balance of the two financing and financing has shrunk by 8.798 billion yuan, and the leveraged funds have increased significantly by 64 shares. Post date April 28, 2022 — 15:43 Post Lock Read More Changsheng Emerging Growth Mixed Net Worth Down 4.53% Post date April 26, 2022 — 07:02 Post Lock Read More Changsheng Internet + mixed net worth fell 4.64%_Sina Finance_Sina.com Post date April 26, 2022 — 06:56 Post Lock Read More 4.525 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 25, 2022 — 18:15 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational sadness in medicine, long-lasting can be more joyful, postal courier tracking number, postal courier inquiry, postal courier parcel inquiry, postal courier parcel inquiry Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term. Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term Post date April 24, 2022 — 15:31 Post Lock Read More 2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year. Post date April 18, 2022 — 13:42 Post Lock Read More Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code) Post date May 2, 2022 — 11:17 Post Lock Read More 45 stocks received institutional buy ratings today, 12 stocks rose more than 20%_Oriental Fortune Network Post date April 29, 2022 — 19:37 Post Lock Read More The balance of the two financing and financing has shrunk by 8.798 billion yuan, and the leveraged funds have increased significantly by 64 shares. Post date April 28, 2022 — 15:43 Post Lock Read More Changsheng Emerging Growth Mixed Net Worth Down 4.53% Post date April 26, 2022 — 07:02 Post Lock Read More Changsheng Internet + mixed net worth fell 4.64%_Sina Finance_Sina.com Post date April 26, 2022 — 06:56 Post Lock Read More 4.525 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 25, 2022 — 18:15 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational sadness in medicine, long-lasting can be more joyful, postal courier tracking number, postal courier inquiry, postal courier parcel inquiry, postal courier parcel inquiry Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term. Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term Post date April 24, 2022 — 15:31 Post Lock Read More 2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year. Post date April 18, 2022 — 13:42 Post Lock Read More Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
45 stocks received institutional buy ratings today, 12 stocks rose more than 20%_Oriental Fortune Network Post date April 29, 2022 — 19:37 Post Lock Read More The balance of the two financing and financing has shrunk by 8.798 billion yuan, and the leveraged funds have increased significantly by 64 shares. Post date April 28, 2022 — 15:43 Post Lock Read More Changsheng Emerging Growth Mixed Net Worth Down 4.53% Post date April 26, 2022 — 07:02 Post Lock Read More Changsheng Internet + mixed net worth fell 4.64%_Sina Finance_Sina.com Post date April 26, 2022 — 06:56 Post Lock Read More 4.525 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 25, 2022 — 18:15 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational sadness in medicine, long-lasting can be more joyful, postal courier tracking number, postal courier inquiry, postal courier parcel inquiry, postal courier parcel inquiry Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term. Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term Post date April 24, 2022 — 15:31 Post Lock Read More 2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year. Post date April 18, 2022 — 13:42 Post Lock Read More Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The balance of the two financing and financing has shrunk by 8.798 billion yuan, and the leveraged funds have increased significantly by 64 shares. Post date April 28, 2022 — 15:43 Post Lock Read More Changsheng Emerging Growth Mixed Net Worth Down 4.53% Post date April 26, 2022 — 07:02 Post Lock Read More Changsheng Internet + mixed net worth fell 4.64%_Sina Finance_Sina.com Post date April 26, 2022 — 06:56 Post Lock Read More 4.525 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 25, 2022 — 18:15 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational sadness in medicine, long-lasting can be more joyful, postal courier tracking number, postal courier inquiry, postal courier parcel inquiry, postal courier parcel inquiry Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term. Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term Post date April 24, 2022 — 15:31 Post Lock Read More 2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year. Post date April 18, 2022 — 13:42 Post Lock Read More Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Changsheng Emerging Growth Mixed Net Worth Down 4.53% Post date April 26, 2022 — 07:02 Post Lock Read More Changsheng Internet + mixed net worth fell 4.64%_Sina Finance_Sina.com Post date April 26, 2022 — 06:56 Post Lock Read More 4.525 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 25, 2022 — 18:15 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational sadness in medicine, long-lasting can be more joyful, postal courier tracking number, postal courier inquiry, postal courier parcel inquiry, postal courier parcel inquiry Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term. Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term Post date April 24, 2022 — 15:31 Post Lock Read More 2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year. Post date April 18, 2022 — 13:42 Post Lock Read More Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Changsheng Internet + mixed net worth fell 4.64%_Sina Finance_Sina.com Post date April 26, 2022 — 06:56 Post Lock Read More 4.525 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 25, 2022 — 18:15 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational sadness in medicine, long-lasting can be more joyful, postal courier tracking number, postal courier inquiry, postal courier parcel inquiry, postal courier parcel inquiry Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term. Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term Post date April 24, 2022 — 15:31 Post Lock Read More 2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year. Post date April 18, 2022 — 13:42 Post Lock Read More Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
4.525 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 25, 2022 — 18:15 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational sadness in medicine, long-lasting can be more joyful, postal courier tracking number, postal courier inquiry, postal courier parcel inquiry, postal courier parcel inquiry Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term. Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term Post date April 24, 2022 — 15:31 Post Lock Read More 2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year. Post date April 18, 2022 — 13:42 Post Lock Read More Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Pharmaceutical Industry Weekly Report: Short-term irrational sadness in medicine, long-lasting can be more joyful, postal courier tracking number, postal courier inquiry, postal courier parcel inquiry, postal courier parcel inquiry Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term. Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term Post date April 24, 2022 — 15:31 Post Lock Read More 2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year. Post date April 18, 2022 — 13:42 Post Lock Read More Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term. Post date April 24, 2022 — 15:31 Post Lock Read More Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term Post date April 24, 2022 — 15:31 Post Lock Read More 2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year. Post date April 18, 2022 — 13:42 Post Lock Read More Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term Post date April 24, 2022 — 15:31 Post Lock Read More 2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year. Post date April 18, 2022 — 13:42 Post Lock Read More Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year. Post date April 18, 2022 — 13:42 Post Lock Read More Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted. Post date April 18, 2022 — 13:25 Post Lock Read More Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 14, 2022 — 14:22 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
[Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net Post date April 12, 2022 — 10:55 Post Lock Read More Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net Post date April 7, 2022 — 15:09 Post Lock Read More April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
April 2022 Investment Monthly Report of the Pharmaceutical Industry: Performance + Policies + Valuation, the Bottom-Up Industry Ushers in Good Layout Opportunities Post date April 6, 2022 — 12:41 Post Lock Read More
Caishen.CoCaishen.Co